Swiss National Bank’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-40,400
| Closed | -$187K | – | 2599 |
|
|
2019
Q1 | $187K | Hold |
40,400
| – | – | ﹤0.01% | 2497 |
|
|
2018
Q4 | $141K | Hold |
40,400
| – | – | ﹤0.01% | 2531 |
|
|
2018
Q3 | $407K | Hold |
40,400
| – | – | ﹤0.01% | 2448 |
|
|
2018
Q2 | $292K | Hold |
40,400
| – | – | ﹤0.01% | 2512 |
|
|
2018
Q1 | $244K | Buy |
40,400
+4,500
| +13% | +$37.2K | ﹤0.01% | 2470 |
|
|
2017
Q4 | $345K | Hold |
35,900
| – | – | ﹤0.01% | 2478 |
|
|
2017
Q3 | $319K | Hold |
35,900
| – | – | ﹤0.01% | 2474 |
|
|
2017
Q2 | $454K | Hold |
35,900
| – | – | ﹤0.01% | 2429 |
|
|
2017
Q1 | $377K | Hold |
35,900
| – | – | ﹤0.01% | 2448 |
|
|
2016
Q4 | $330K | Hold |
35,900
| – | – | ﹤0.01% | 2502 |
|
|
2016
Q3 | $423K | Sell |
35,900
-4,200
| -10% | -$63.8K | ﹤0.01% | 2404 |
|
|
2016
Q2 | $519K | Sell |
40,100
-4,200
| -9% | -$61.2K | ﹤0.01% | 2337 |
|
|
2016
Q1 | $686K | Buy |
44,300
+7,700
| +21% | +$146K | ﹤0.01% | 2135 |
|
|
2015
Q4 | $1.05M | Hold |
36,600
| – | – | ﹤0.01% | 1794 |
|
|
2015
Q3 | $1.04M | Buy |
36,600
+4,600
| +14% | +$169K | ﹤0.01% | 1759 |
|
|
2015
Q2 | $1.15M | Buy |
32,000
+1,000
| +3% | +$31.1K | ﹤0.01% | 1710 |
|
|
2015
Q1 | $901K | Hold |
31,000
| – | – | ﹤0.01% | 1813 |
|
|
2014
Q4 | $653K | Buy |
31,000
+1,600
| +5% | +$31.6K | ﹤0.01% | 2002 |
|
|
2014
Q3 | $570K | Hold |
29,400
| – | – | ﹤0.01% | 2019 |
|
|
2014
Q2 | $459K | Buy |
29,400
+15,600
| +113% | +$252K | ﹤0.01% | 2206 |
|
|
2014
Q1 | $286K | Buy |
13,800
+4,200
| +44% | +$83.3K | ﹤0.01% | 2339 |
|
|
2013
Q4 | $124K | Buy |
+9,600
| New | +$133K | ﹤0.01% | 2458 |
|
Other funds holding INSY
WS
Swiss National Bank's INSY Position: Q2 2019 in Review
Swiss National Bank sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 40,400 shares — an estimated $187K sold.
Swiss National Bank first reported a position in INSY in Q4 2013 and held it in 22 quarters. The position peaked at $1.15M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Swiss National Bank reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Swiss National Bank sold 40,400 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $187K.
- Swiss National Bank first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 22 quarters.
- Swiss National Bank's Insys Therapeutics, Inc. position peaked at $1.15M in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.